Identification of Macrolide-Resistant Clones of Streptococcus Pyogenes in Portugal

Clin Microbiol Infect. 2006 Jun;12(6):513-8. doi: 10.1111/j.1469-0691.2006.01408.x.

Abstract

Although the overall level of macrolide resistance (27%) has remained stable in Portugal, a rapid inversion in the dominant phenotypes has been noted, with a sharp decrease in the MLS(B) phenotype paralleled by an increase in the M phenotype. To gain further insight into these changes, 325 macrolide-resistant isolates were characterised using a combination of pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). The use of Cfr9I, an isoschizomer of SmaI, to digest M phenotype isolates that were refractory to SmaI digestion allowed direct comparison of MLS(B) and M isolates. The results from PFGE and MLST were highly concordant and identified eight major clones, accounting for 92% of the isolates, each of which was associated exclusively with a single macrolide resistance phenotype. Two major clones were found among MLS(B) isolates, characterised by sequence types (ST) 46 (T12/emm22) and ST52 (T28/emm28), whereas clones characterised by ST39 (T4/emm4) and ST28 (T1/emm1) dominated among M isolates. The clone defined by ST52 corresponded to a bacitracin-resistant clone circulating in Europe, and a novel variant expressing other surface antigens (T12/emm22) was detected. The presence of the four major clones has been reported previously in other European countries, suggesting Europe-wide dissemination of a few macrolide-resistant lineages.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacitracin / pharmacology
  • Cluster Analysis
  • Deoxyribonucleases, Type II Site-Specific / metabolism
  • Drug Resistance, Bacterial / genetics*
  • Electrophoresis, Gel, Pulsed-Field / methods
  • Genotype
  • Humans
  • Macrolides / pharmacology*
  • Microbial Sensitivity Tests
  • Phenotype
  • Portugal
  • Sequence Analysis, DNA / methods
  • Streptococcal Infections / microbiology
  • Streptococcus pyogenes / drug effects*
  • Streptococcus pyogenes / genetics*
  • Streptococcus pyogenes / isolation & purification

Substances

  • Macrolides
  • Bacitracin
  • CCCGGG-specific type II deoxyribonucleases
  • Deoxyribonucleases, Type II Site-Specific